Value Bridge — GRANDVIEW MEDICAL CENTER
Current $87M → Target $101M (+$13.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$87.1M
Current EBITDA
$100.7M
Target EBITDA
+$13.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.1M
Payer Mix Optimization
$7.4M
Cost to Collect Reduction
$2.5M
Clean Claim Improvement
$1.8M
Volume & Rate Growth
$12.3M
What This Means
The 7-lever model projects a 16% EBITDA uplift from $87M to $101M. The highest-impact lever is Volume & Rate Growth at $4.9M probability-weighted.
IC talking point: "We see $14M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $150M in equity value creation."